Metraipolis › archive › dc_d59cf7a07eda

Preclinical Prediction of Resistance Mutations and Proposal of Sequential Treatment Strategies for ALK-positive Lung Cancer Using Next-generation ALK Inhibitors — Europe PMC PMID:40993323

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40993323
DOI
10.1007/s11095-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-11-09T18:54:53.008Z
SHA-256 of the archived text
6a9f231a55563b7fa6ba661fa40bdd10598b0a95f2ebc86900dfe2bc9481be0e
Stable URL of this page
https://metraipolis.com/documento/dc_d59cf7a07eda

How to cite

Preclinical Prediction of Resistance Mutations and Proposal of Sequential Treatment Strategies for ALK-positive Lung Cancer Using Next-generation ALK Inhibitors — Europe PMC PMID:40993323 — Europe PMC (en), https://europepmc.org/article/MED/40993323 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d59cf7a07eda (Metraipolis archive dc_d59cf7a07eda, sha256 6a9f231a55563b7fa6ba661fa40bdd10598b0a95f2ebc86900dfe2bc9481be0e)
BibTeX
@misc{dcd59cf7a07eda,
  title = {Preclinical Prediction of Resistance Mutations and Proposal of Sequential Treatment Strategies for ALK-positive Lung Cancer Using Next-generation ALK Inhibitors — Europe PMC PMID:40993323},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40993323},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d59cf7a07eda; sha256 6a9f231a55563b7fa6ba661fa40bdd10598b0a95f2ebc86900dfe2bc9481be0e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40993323. Agents can read the archived copy with the MCP tool read_document.